1. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease;RN Foley;Am J Kidney Dis,1996
2. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients;DL Regidor;J Am Soc Nephrol,2006
3. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study;J Pascual;Clin Nephrol,1991
4. Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients;KL Johansen;Nephrol Dial Transplant,2012
5. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis;K Kalantar-Zadeh;J Am Soc Nephrol,2001